Nutrition
Volume 25, Issue 11 , Pages 1085-1093 , November 2009

Proteomics at the center of nutrigenomics: Comprehensive molecular understanding of dietary health effects

Received 29 May 2009 ,Accepted 31 May 2009.

References 

  1. Kussmann M, Affolter M, Nagy K, Holst B, Fay LB. Mass spectrometry in nutrition: understanding dietary health effects at the molecular level. Mass Spectrom Rev. 2007;26:727–750
  2. Kussmann M, Raymond F, Affolter M. OMICS-driven biomarker discovery in nutrition and health. J Biotechnol. 2006;124:758–787
  3. Kussmann M, Fay LB. Nutrigenomics and personalized nutrition: science and concept. Pers Med. 2008;5:447–455
  4. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet. 2004;5:71–118
  5. Kaput J. Nutrigenomics research for personalized nutrition and medicine. Curr Opin Biotechnol. 2008;19:110–120
  6. Fay LB, German JB. Personalizing foods: is genotype necessary?. Curr Opin Biotechnol. 2008;19:121–128
  7. Gallou-Kabani C, Vige A, Gross MS, Junien C. Nutri-epigenomics: lifelong remodelling of our epigenomes by nutritional and metabolic factors and beyond. Clin Chem Lab Med. 2007;45:321–327
  8. Junien C, Gallou-Kabani C, Vige A, Gross MS. [Nutritionnal epigenomics: consequences of unbalanced diets on epigenetics processes of programming during lifespan and between generations]. Ann Endocrinol (Paris). 2005;66(pt 3):2S19–228
  9. Kussmann M, Affolter M. Proteomic methods in nutrition. Curr Opin Clin Nutr Metab Care. 2006;9:575–583
  10. Kussmann M, Affolter M, Fay LB. Proteomics in nutrition and health. Comb Chem High Throughput Screen. 2005;8:679–696
  11. Kussmann M, Daniel H. Editorial overview. Curr Opin Biotechnol. 2008;19:63–65
  12. Kussmann M, Rezzi S, Daniel H. Profiling techniques in nutrition and health research. Curr Opin Biotechnol. 2008;19:83–99
  13. Fenn JB. Electrospray wings for molecular elephants (Nobel lecture). Angew Chem Int Ed Engl. 2003;42:3871–3894
  14. Tanaka K. The origin of macromolecule ionization by laser irradiation (Nobel lecture). Angew Chem Int Ed Engl. 2003;42:3860–3870
  15. Makarov A, Denisov E, Kholomeev A, Balschun W, Lange O, Strupat K, et al. Performance evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal Chem. 2006;78:2113–2120
  16. Nielsen ML, Savitski MM, Zubarev RA. Improving protein identification using complementary fragmentation techniques in Fourier transform mass spectrometry. Mol Cell Proteomics. 2005;4:835–845
  17. Jacobs JM, Adkins JN, Qian WJ, Liu T, Shen Y, Camp DG, et al. Utilizing human blood plasma for proteomic biomarker discovery. J Proteome Res. 2005;4:1073–1085
  18. Gong Y, Li X, Yang B, Ying W, Li D, Zhang Y, et al. Different immunoaffinity fractionation strategies to characterize the human plasma proteome. J Proteome Res. 2006;5:1379–1387
  19. Thingholm TE, Jensen ON, Larsen MR. Analytical strategies for phosphoproteomics. Proteomics. 2009;9:1451–1468
  20. Mechref Y, Madera M, Novotny MV. Glycoprotein enrichment through lectin affinity techniques. Methods Mol Biol. 2008;424:373–396
  21. Wollscheid B, Bausch-Fluck D, Henderson C, O'Brien R, Bibel M, Schiess R, et al. Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins. Nat Biotechnol. 2009;27:378–386
  22. Sellers KF, Miecznikowski J, Viswanathan S, Minden JS, Eddy WF. Lights, camera, action! Systematic variation in 2-D difference gel electrophoresis images. Electrophoresis. 2007;28:3324–3332
  23. Swanson SK, Washburn MP. The continuing evolution of shotgun proteomics. Drug Discov Today. 2005;10:719–725
  24. Moresco JJ, Dong MQ, Yates JR. Quantitative mass spectrometry as a tool for nutritional proteomics. Am J Clin Nutr. 2008;88:597–604
  25. Panchaud A, Hansson J, Affolter M, Bel RR, Piu S, Moreillon P, et al. ANIBAL, stable isotope-based quantitative proteomics by aniline and benzoic acid labeling of amino and carboxylic groups. Mol Cell Proteomics. 2008;7:800–812
  26. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol. 1999;17:994–999
  27. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3:1154–1169
  28. Thompson A, Schafer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem. 2003;75:1895–1904
  29. de Godoy LM, Olsen JV, de Souza GA, Li G, Mortensen P, Mann M. Status of complete proteome analysis by mass spectrometry: SILAC labeled yeast as a model system. Genome Biol. 2006;7:R50
  30. Mueller LN, Brusniak MY, Mani DR, Aebersold R. An assessment of software solutions for the analysis of mass spectrometry based quantitative proteomics data. J Proteome Res. 2008;7:51–61
  31. Wong JW, Sullivan MJ, Cagney G. Computational methods for the comparative quantification of proteins in label-free LCn-MS experiments. Brief Bioinform. 2008;9:156–165
  32. Brun V, Masselon C, Garin J, Dupuis A. Isotope dilution strategies for absolute quantitative proteomics. J Proteomics. 2009;Article in press; doi:10.1016/j.jprot.2009.03.007
  33. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc Natl Acad Sci U S A. 2003;100:6940–6945
  34. Pratt JM, Simpson DM, Doherty MK, Rivers J, Gaskell SJ, Beynon RJ. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat Protoc. 2006;1:1029–1043
  35. Dupuis A, Hennekinne JA, Garin J, Brun V. Protein standard absolute quantification (PSAQ) for improved investigation of staphylococcal food poisoning outbreaks. Proteomics. 2008;8:4633–4636
  36. Mallick P, Schirle M, Chen SS, Flory MR, Lee H, Martin D, et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nat Biotechnol. 2007;25:125–131
  37. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008;4:222
  38. Yocum AK, Chinnaiyan AM. Current affairs in quantitative targeted proteomics: multiple reaction monitoring–mass spectrometry. Brief Funct Genomic Proteomic. 2009;8:145–157
  39. Schiess R, Wollscheid B, Aebersold R. Targeted proteomic strategy for clinical biomarker discovery. Mol Oncol. 2009;3:33–44
  40. Anderson NL, Anderson NG, Pearson TW, Borchers CH, Paulovich AG, Patterson SD, et al. A human proteome detection and quantitation project. Mol Cell Proteomics. 2009;8:883–886
  41. Zubarev RA, Hakansson P, Sundqvist B. Accuracy requirements for peptide characterization by monoisotopic molecular mass measurements. Anal Chem. 1996;68:4060–4063
  42. Conrads TP, Anderson GA, Veenstra TD, Pasa Tolic L, Smith RD. Utility of accurate mass tags for proteome-wide protein identification. Anal Chem. 2000;72:3349–3354
  43. Pappin DJ. Peptide mass fingerprinting using MALDI-TOF mass spectrometry. Methods Mol Biol. 1997;64:165–173
  44. Schuerenberg M, Luebbert C, Eickhoff H, Kalkum M, Lehrach H, Nordhoff E. Prestructured MALDI-MS sample supports. Anal Chem. 2000;72:3436–3442
  45. Mann M, Wilm M. Error-tolerant identification of peptides in sequence databases by peptide sequence tags. Anal Chem. 1994;33:4390–4399
  46. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom. 1994;5:976–989
  47. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20:3551–3567
  48. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002;74:5383–5392
  49. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem. 2003;75:4646–4658
  50. Urfer W, Grzegorczyk M, Jung K. Statistics for proteomics: a review of tools for analyzing experimental data. Proteomics. 2006;6:48–55
  51. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods. 2007;4:207–214
  52. Staab CA, Ceder R, Jagerbrink T, Nilsson JA, Roberg K, Jornvall H, et al. Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma. J Proteome Res. 2007;6:3705–3717
  53. Fuchs D, Winkelmann I, Johnson IT, Mariman E, Wenzel U, Daniel H. Proteomics in nutrition research: principles, technologies and applications. Br J Nutr. 2005;94:302–314
  54. Kussmann M, Blum-Sperisen S. OMICS-derived targets for inflammatory gut disorders: opportunities for the development of nutrition related biomarkers. Endocr Metab Immune Disord Drug Targets. 2007;7:271–287
  55. Kussmann M, Affolter M. Proteomics and metabonomics routes towards obesity. In:  Sorensen T,  Clément K editor. Obesity—genomics and postgenomics. New York: Informa Health Care; 2008;p. 527–536
  56. Fuchs D, Piller R, Linseisen J, Daniel H, Wenzel U. The human peripheral blood mononuclear cell proteome responds to a dietary flaxseed-intervention and proteins identified suggest a protective effect in atherosclerosis. Proteomics. 2007;7:3278–3288
  57. Breikers G, van Breda SG, Bouwman FG, van Herwijnen MH, Renes J, Mariman EC, et al. Potential protein markers for nutritional health effects on colorectal cancer in the mouse as revealed by proteomics analysis. Proteomics. 2006;6:2844–2852
  58. tom-Dieck H, Doring F, Fuchs D, Roth HP, Daniel H. Transcriptome and proteome analysis identifies the pathways that increase hepatic lipid accumulation in zinc-deficient rats. J Nutr. 2005;135:199–205
  59. Hansen MB. The enteric nervous system I: organisation and classification. Pharmacol Toxicol. 2003;92:105–113
  60. Marvin-Guy L, Lopes LV, Affolter M, Courtet-Compondu MC, Wagniere S, Bergonzelli GE, et al. Proteomics of the rat gut: analysis of the myenteric plexus-longitudinal muscle preparation. Proteomics. 2005;5:2561–2569
  61. Lopes LV, Marvin-Guy LF, Fuerholz A, Affolter M, Ramadan Z, Kussmann M, et al. Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in life. J Proteomics. 2008;71:80–88
  62. Barceló-Batllori S, André M, Servis C, Lévy N, Takikawa O, Michetti P, et al. Proteomic analysis of cytokine-induced proteins in human intestinal epithelial cells: implications for inflammatory bowel diseases. Proteomics. 2002;2:551–560
  63. Wood JD, Alpers DH, Andrews PL. Fundamentals of neurogastroenterology. Gut. 1999;45(suppl 2):II6–II16
  64. Hang P, Sangild PT, Sit WH, Ngai HH, Xu R, Siggers JL, et al. Temporal proteomic analysis of intestine developing necrotizing enterocolitis following enteral formula feeding to preterm pigs. J Proteome Res. 2009;8:72–81
  65. Stierum R, Burgemeister R, van Helvoort A, Peijnenburg A, Schutze K, Seidelin M, et al. Functional food ingredients against colorectal cancer. An example project integrating functional genomics, nutrition and health. Nutr Metab Cardiovasc Dis. 2001;11(suppl):94–98
  66. Tan S, Seow TK, Liang RCMY, Koh S, Lee CPC, Chung MCM, et al. Proteome analysis of butyrate-treated human colon cancer cells (HT-29). Int J Cancer. 2002;98:523–531
  67. Herzog A, Kindermann B, Doring F, Daniel H, Wenzel U. Pleiotropic molecular effects of the pro-apoptotic dietary constituent flavone in human colon cancer cells identified by protein and mRNA expression profiling. Proteomics. 2004;4:2455–2464
  68. Aalinkeel R, Bindukumar B, Reynolds JL, Sykes DE, Mahajan SD, Chadha KC, et al. The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90. Prostate. 2008;68:1773–1789
  69. Fong LY, Zhang L, Jiang Y, Farber JL. Dietary zinc modulation of COX-2 expression and lingual and esophageal carcinogenesis in rats. J Natl Cancer Inst. 2005;97:40–50
  70. Zhang L, Perdomo G, Kim DH, Qu S, Ringquist S, Trucco M, et al. Proteomic analysis of fructose-induced fatty liver in hamsters. Metabolism. 2008;57:1115–1124
  71. Davis CD, Milner J. Frontiers in nutrigenomics, proteomics, metabolomics and cancer prevention. Mutat Res. 2004;551:51–64
  72. Knowles LM, Milner JA. Diallyl disulfide induces ERK phosphorylation and alters gene expression profiles in human colon tumor cells. J Nutr. 2003;133:2901–2906
  73. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA. 2002;99:11908–11913
  74. Panchaud A, Affolter M, Moreillon P, Kussmann M. Experimental and computational approaches to quantitative proteomics: status quo and outlook. J Proteomics. 2008;71:19–33
  75. Mancone C, Amicone L, Fimia GM, Bravo E, Piacentini M, Tripodi M, et al. Proteomic analysis of human very low-density lipoprotein by two-dimensional gel electrophoresis and MALDI-TOF/TOF. Proteomics. 2007;7:143–154
  76. Bantscheff M, Eberhard D, Abraham Y, Bastuck S, Boesche M, Hobson S, et al. Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors. Nat Biotechnol. 2007;25:1035–1044
  77. Mallick P, Schirle M, Chen SS, Flory MR, Lee H, Martin D, et al. Computational prediction of proteotypic peptides for quantitative proteomics. Nat Biotechnol. 2007;25:125–131
  78. Anderson L, Hunter CL. Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics. 2006;5:573–588
  79. Nicholson JK, Connelly J, Lindon JC, Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov. 2002;1:153–161
  80. Doherty MK, Beynon RJ. Protein turnover on the scale of the proteome. Expert Rev Proteomics. 2006;3:97–110
  81. Siffert W. G protein polymorphisms in hypertension, atherosclerosis, and diabetes. Annu Rev Med. 2005;56:17–28
  82. Chen Y, Rollins J, Paigen B, Wang X. Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metab. 2007;6:164–179
  83. Holtmann G, Siffert W, Haag S, Mueller N, Langkafel M, Senf W, et al. G-protein beta 3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology. 2004;126:971–979
  84. Beck HC, Nielsen EC, Matthiesen R, Jensen LH, Sehested M, Finn P, et al. Quantitative proteomic analysis of post-translational modifications of human histones. Mol Cell Proteomics. 2006;5:1314–1325
  85. Bonenfant D, Coulot M, Towbin H, Schindler P, van Oostrum J. Characterization of histone H2A and H2B variants and their post-translational modifications by mass spectrometry. Mol Cell Proteomics. 2006;5:541–552

PII: S0899-9007(09)00244-5

doi: 10.1016/j.nut.2009.05.022

Nutrition
Volume 25, Issue 11 , Pages 1085-1093 , November 2009

Article Tools

* Image Usage & Resolution